Consonance Capital Management LP 13D and 13G filings for Aurinia Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2021-02-17 2:22 pm Sale | 2020-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH | Consonance Capital Management LP | 0 0.000% | -6,058,505 (Position Closed) | Filing |
2021-02-16 2:19 pm Sale | 2020-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH | Consonance Capital Management LP | 6,058,505 11.000% | -567,166 (-8.56%) | Filing |
2020-02-14 1:18 pm Purchase | 2019-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH | Consonance Capital Management LP | 6,625,671 3.480% | 6,625,671 (New Position) | Filing |